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Results: 4719 patients (88.6%) were analysed (2781 with 
knee, 1553 with hip, and 385 with hip and knee osteoarthritis). 
Mean scores of the WOMAC (range 0-100) were 48.74-17.9, 
47.24-17.4, and 52.24-17.5 for the 17, nine, and eight item- 
versions respectively. We observed no difference in mean scores 
between knee and hip osteoarthritis. For the three versions of the 
questionnaire, the Cronbach coefficient values were high (0.96, 
0.91, and 0.92 respectively). For each osteoarthritis location, fac- 
tor analysis of the 17-item version extracted two similar factors 
which could not be clinically characterised, explaining 67% of the 
total variance for hip OA and 63% of the total variance for knee 
OA. Factor analysis of the nine-item version extracted one fac- 
tor explaining 60% of the total variance for knee and two fac- 
tors (which could not be clinically characterised) explaining 72% 
of the total variance for hip osteoarthritis. The eight-item version 
was one-dimensional for knee and hip OA, explaining 61.0% and 
61.5% of total variance. The mean scores of the three WOMAC 
versions were highly correlated but were weakly correlated with 
pain scores (r values between 0.42 and 0.53). 
Conclusions: Mean scores of the 3 versions of the WOMAC 
questionnaire, section C are highly correlated, but the eight-item 
version has the advantage of being one-dimensional for both lo- 
cations of the disease. Disability assessed by the WOMAC ques- 
tionnaire is similar for both hip and knee osteoarthritis. 
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Introduction: There are many treatment pathways for os- 
teoarthritis of the knee; however the outcome may not match the 
patient's expectations. The purpose of this study was to identify 
the expectations of treatment in patients with osteoarthritis of the 
knee. 
Methods: A 20 item validated knee surgery expectation survey 
was completed by 130 individuals, 50 years or older, who were 
diagnosed with knee osteoarthritis. There were 54 women and 
76 men with a mean age of 63 years(range 50 - 91). 
Results: Avoid future knee degeneration was the most com- 
mon expectation rated very important(85%), followed by improve 
ability to maintain health(79%), have confidence in knee(69%), 
and improve ability to walk(69%). The least common expecta- 
tion was for the knee to be back to way it was before the prob- 
lem started, followed by improve ability to run. Gender was as- 
sociated (p<0.05) with the following expectations: avoid future 
degeneration(more important o females), improve ability to do 
stairs(more important o females), improve ability to kneel(more 
important o males), and stop knee from giving way when stop- 
ping quickly(more important to males). Age was associated 
(p<0.05) with pain relief(more important to younger) and improve 
ability to participate in sport(more important to younger). Improve 
ability to maintain health was more important to older individuals, 
as was avoid future degeneration of the knee. 
Conclusions: Patient expectations are influenced by age and 
gender. These differences are important in clinical decision mak- 
ing. Further understanding of patients' expectations of treatment 
may improve treatment outcome and patient satisfaction. 
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Aim of study: After observing that three patients with both knee 
osteoarthritis and psoriasis treated with chondroitin sulfate ex- 
perienced a marked improvement of skin lesions, we decided to 
study more cases due to the encouraging preliminary results. 
Here, we describe the clinical and histopathological results of 
eleven patients with both osteoarthritis and psoriasis treated with 
oral chondroitin sulfate. 
Methods: Eleven adult patients with knee osteoarthritis and long- 
standing moderate to severe psoriasis resistant to conventional 
therapy received 800 mg/day of chondroitin sulfate (Bioiberica 
S.A., Barcelona, Spain) for two months. Skin biopsies were ob- 
tained before and after treatment. 
Results: Clinically, all patients but one presented a dramatic im- 
provement of the condition of the skin with a reduction of swelling, 
redness, flaking, and itching, increase in the hydration and soft- 
ening of the skin, and amelioration of scaling. One patient expe- 
rienced clearance of psoriasis. Histopathologically, there was a 
statistically significant decrease in epidermal thickness (-29%), 
a decrease in the thickness between the stratum basale and 
the stratum granulosum (-31%), a significant improvement of the 
degree of psoriasis activity (-49%), and a decrease in the ker- 
atinocyte proliferation index (-27%). The substitution of paraker- 
atotic keratinization by orthokeratotic keratinization was also ob- 
served. 
Conclusions: The administration of chondroitin sulfate resulted 
in a marked improvement of the psoriatic lesions. Therefore, the 
confirmation of these findings in controlled prospective studies 
could represent an important advance in the therapeutic arma- 
mentarium for patients with psoriasis given the excellent safety 
profile of chondroitin sulfate. 
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Aims: To compare the effectiveness of Ostenil Mini (a Sodium 
Hyaluronate designed specifically for small joint Osteoarthritis) to 
a standard injection of Depomedrone for base of thumb arthritis. 
Methods: After obtaining ethical approval 20 patients were re- 
cruited from the Rheumatology and Hand clinics at a busy dis- 
trict general hospital and gave consent to be included in the trial. 
Patients received either an injection of Depomedrone or an in- 
jection of Ostenil mini. Due to bilateral disease there were 23 
injections, 10 of Depomedrone and 13 of Ostenil mini. Most pa- 
tients were female; 2 males, and only 2 were left-handed, both 
of these had isolated left sided disease. Each patient was as- 
sessed prior to the injection using the Patient Rated Wrist Evalua- 
